InsidersTradesSigma
Follow the 迈瑞医疗 share price and the full directors' dealings record of the company, a publicly traded company based in China. Shares are quoted on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 迈瑞医疗 has recorded 14 public disclosures. Market capitalisation: €181.7bn. The latest transaction was disclosed on 3 June 2026 (Purchase). Among the most active insiders: LI XITING. All data is accessible without an account.
Analysts rate 迈瑞医疗 Strong Buy (bullish), based on 18 analysts. Average price target: CN¥232.51.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
14 of 14 declarations
Mindray Medical es una empresa centrada en el desarrollo y la fabricación de equipos médicos y soluciones de diagnóstico. Cotiza en el mercado XSHE y es conocida por sus innovaciones en el sector de la salud.